List of works - Pierre Clerson

A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertension

scientific article published on 31 August 2015

Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease

scientific article

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.

scientific article

Could the Cochin risk prediction score be applied in daily practice to predict pulmonary hypertension in systemic sclerosis? Comment on the article by Meune et al

scholarly article by Eric Hachulla et al published 25 May 2012 in Arthritis and Rheumatism

Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

article

Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension

scientific article published on 29 April 2020

Is Pulmonary Arterial Hypertension Really a Late Complication of Systemic Sclerosis?

Is pulmonary arterial hypertension really a late complication of systemic sclerosis?

scientific article published on 8 May 2009

Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era.

scientific article published on 11 October 2007

Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry

scientific article published on 26 August 2017

Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome

scientific article published on 8 February 2010

Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study

scientific article published on 27 January 2009

Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximab

scientific article

Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long-term survival

article

Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era.

scientific article

The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France

article

Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population

scientific article published on 17 January 2015

List of works by Pierre Clerson

A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertension

Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.

Could the Cochin risk prediction score be applied in daily practice to predict pulmonary hypertension in systemic sclerosis? Comment on the article by Meune et al

Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension

Is Pulmonary Arterial Hypertension Really a Late Complication of Systemic Sclerosis?

Is pulmonary arterial hypertension really a late complication of systemic sclerosis?

Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era.

Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry

Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome

Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study

Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximab

Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long-term survival

Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era.

The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France

Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population